Adalimumab
Get a Quick Quote Now
Select Packaging
Product Description
Product
Adalimumab
CAS
331731-18-1
Formula
C6428H9912N1694O1987
Synonym
Ig gamma-1 chain C region, Adalimumab, D2E7, HSDB 7851, Humira, Immunoglobulin G1, anti-(human tumor necrosis factor), (human monoclonal D2E7 heavy chain), disulfide with human, monoclonal D2E7 light chain, dimer. Molecular weight is, approximately 148,000 daltons, LU200134, Trudexa, UNII-FYS6T7F842, Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Molecular weight
144190.3
Notes
Adalimumab is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Adalimumab
Product Description
Product
Adalimumab
CAS
331731-18-1
Formula
C6428H9912N1694O1987
Synonym
Ig gamma-1 chain C region, Adalimumab, D2E7, HSDB 7851, Humira, Immunoglobulin G1, anti-(human tumor necrosis factor), (human monoclonal D2E7 heavy chain), disulfide with human, monoclonal D2E7 light chain, dimer. Molecular weight is, approximately 148,000 daltons, LU200134, Trudexa, UNII-FYS6T7F842, Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Molecular weight
144190.3
Notes
Adalimumab is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
